Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer
Spiceland, Clayton M. , Olivier, Kenneth R. , Jatoi, Aminah

Journal of Palliative Medicine | July 28, 2015 | Volume: 18 | Issue: 8 | Pages: 707-710

10.1089/jpm.2015.0097 | PMID 26218580 Get It

Abstract Background: Numerous studies have focused on the treatment of non-small cell lung cancer patients with brain metastases. However, to our knowledge, few have sought to examine outcomes in patients who required whole brain radiation and developed radiation-refractory disease. Methods: This study examined the medical records of all non-small cell lung cancer patients who developed brain metastases between 2004 and 2013, required whole brain radiation, and received their cancer treatment at the Mayo Clinic in Rochester, Minnesota. Results: A total of 141 patients, most of whom were symptomatic, met the above criteria. Of these, 33 (23%) did not tolerate a corticosteroid taper and were therefore deemed to have radiation-refractory disease. The median survival of patients with and without radiation-refractory disease was 3.12 and 4.27 months, respectively, (hazard ratio [HR]: 0.65 [95% confidence interval (CI): 0.44–0.99]; p =0.04 by log rank test). In a subgroup analysis of patients with radiation-refractory disease ( n =33) and radio-responsive disease ( n =43), median survival was 3.12 and 5.94 months, respectively (HR: 0.43 [95% CI: 0.26–0.70]). Among patients with radiation-refractory disease, 12 received chemotherapy after radiation, and two received erlotinib. Systemic therapy was associated with improved symptoms in two patients but did not appear to improve survival. Conclusion: Non-small cell lung cancer patients with radiation-refractory brain metastases represent a small subgroup who have a short survival and who appear to derive minimal benefit from systemic cancer therapy.
Prevalence of Sodium and Fluid Restriction Recommendations for Patients with Pulmonary Hypertension
Zeiger, Tonya K., Cobo, Giovanna, Dillingham, Christine, Burger, Charles, Zeiger, Tonya, Cobo, Giovanna Cueva

Healthcare | July 28, 2015 | Volume: 3 | Issue: 3 | Pages: 630-636

10.3390/healthcare3030630 | PMID 27417785 Get It

Background: Patients with pulmonary hypertension (PH) are often afflicted with the consequences of right heart failure including volume overload. Counseling to assist the patient in the dietary restriction of sodium and fluid may be underutilized. Methods: Consecutive patients seen in the PH Clinic at Mayo Clinic in Florida from June to November 2013. Results: 100 patients were included; 70 were women and most had group 1 PH (n = 69). Patient characteristics using mean (±SD) were: Age 63 ± 13 years, functional class 3 ± 1, brain natriuretic peptide 302 ± 696 pg/mL, 6-min walk 337 ± 116 m, right atrial pressure 8 ± 5 mmHg, and mean pulmonary artery pressure 42 ± 13 mmHg. Overall, 79 had had complete (32) or partial instruction (47) and 21 had no prior counseling to restrict sodium or fluid. Of the 47 with partial instruction, 42 received complete education during the PH Clinic visit. Of the 21 without prior instruction, 19 received complete education during the PH visit. Seven patients with the opportunity to have their education enhanced or provided did not receive any additional counseling during the PH visit. Conclusion: Sodium and fluid restriction is an important but perhaps underutilized strategy to manage volume overload in patients with right heart failure. Focused questioning and education may permit an increase in the patients receiving instruction in this regard.
Gastrointestinal Metastases from Breast Cancer, a Comprehensive Review
Wiisanen, Jeffrey M., Kaur, Judith S.

The Breast Journal | July 28, 2015 | Volume: 21 | Issue: 5 | Pages: 572-573

10.1111/tbj.12464 | PMID 26215570 Get It

Reply to M.H. Gail et al
Pankratz, V. Shane , Vierkant, Robert A. , Frank, Ryan D. , Hartmann, Lynn C., Degnim, Amy C. , Vierkant, Robert A

Journal of Clinical Oncology | July 28, 2015 | Volume: 33 | Issue: 25 | Pages: 2830-2831

10.1200/jco.2015.62.5756 | PMID 26215951 Get It

Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells
Yu, Changming , Pike, Gennett M., Rinkoski, Tommy A. , Correia, Cristina , Kaufmann, Scott H. , Federspiel, Mark J. , Kaufmann, Scott H , Correia, Cristina

Proceedings of the National Academy of Sciences | July 27, 2015 | Volume: 112 | Issue: 32 | Pages: 9860-9865

10.1073/pnas.1414754112 | PMID 26216971 Get It

Significance There is a need for a robust and efficient eukaryotic polypeptide display platform for the discovery and affinity maturation of antibodies and other scaffolds, offering a powerful addition to the existing display technologies that use microorganisms. This study is significant in that it demonstrates just such a technology, avian leukosis virus (ALV) polypeptide display, supplying an innovative and substantive departure from the status quo of antibody display that uses platforms based on microorganisms. The use of eukaryotic cells provides the assurance of maximizing the proper folding, posttranslational modifications, and display of the single-chain Fv antibodies and the virus fusion proteins in virions and on the cell surface. ALV display offers virus and cell display platforms in a eukaryotic expression system.
Labral Morphologic Characteristics in Patients With Symptomatic Acetabular Dysplasia
Beaulé, Paul E. , Clohisy, John C. , Kim, Young-Jo, Millis, Michael B. , Podeszwa, David A. , Schoenecker, Perry L. , Sink, Ernest L. , Sucato, Daniel J. , Zaltz, Ira , Sankar, Wudbhav N. , Peters, Christopher L. , Sierra, Rafael J. , Beaulé, Paul E

The American Journal of Sports Medicine | July 27, 2015 | Volume: 43 | Issue: 9 | Pages: 2152-2156

10.1177/0363546515591262 | PMID 26216104 Get It

Background: The morphologic characteristics of the labrum in patients with symptomatic acetabular dysplasia have been described to some extent in smaller retrospective series, but the need remains to further define these disease characteristics and their importance as a diagnostic feature of hip instability. Purpose: To (1) characterize the morphologic characteristics of the labrum in patients with symptomatic acetabular dysplasia and (2) test the relationships between specific labral variants, severity of dysplasia, and duration of symptoms. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Thirteen surgeons from 10 centers enrolled patients undergoing periacetabular osteotomy (PAO) for symptomatic acetabular dysplasia from 2008 to 2014. Patient demographics, presenting characteristics, preoperative radiographic data, operative data, and intraoperative findings were prospectively collected and retrospectively reviewed. Results: A total of 942 patients (972 hips) met the initial inclusion criteria, with a mean age of 25.2 years (range, 9-51 years; 84% female, 16% male). In addition to having PAO, 52.6% of hips had an anterior arthrotomy and 19.8% had a hip arthroscopy either to perform an osteochondroplasty of the femoral head-neck junction or to address labral pathologic changes. Of these 553 hips in which the labrum was visualized, labral morphologic status was graded as hypertrophic in 50%, normal in 45%, hypoplastic in 4%, and ossified in less than 1%. Decreased lateral center-edge angle and anterior center-edge angle and increased acetabular inclination were associated with labral hypertrophy, but chronicity of symptoms was not. Of the 553 hips, 64% had tears of the labrum, with the majority being degenerative-type tears. Conclusion: Labral pathologic changes are common in patients with symptomatic acetabular dysplasia. Labral hypertrophy, however, is not a universal finding, particularly in hips with mild dysplasia, and therefore should not be considered a reliable diagnostic criterion for instability.
Clinical Reasoning: A 51-year-old woman with weakness and stiff neck
Kassardjian, Charles D. , Milone, Margherita

Neurology | July 27, 2015 | Volume: 85 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000001795 | PMID 26215883 Get It

Arthroscopic Labral Reconstruction of the Hip Using Semitendinosus Allograft
Redmond, John M., Cregar, William M., Martin, Timothy J. , Vemula, S. Pavan, Gupta, Asheesh, Domb, Benjamin G.

Arthroscopy Techniques | July 27, 2015 | Volume: 4 | Issue: 4 | Pages: No page available

10.1016/j.eats.2015.03.002 | PMID 26759770 Get It

Abstract The labrum of the hip is recognized as being important to the stability of the hip and a major cause of hip pain. Damage to the labrum may result in increased joint stress and articular damage. Labral damage is often treated through various methods, among them simple stitch repair, base refixation, and debridement. Labral reconstruction becomes necessary when the labrum is too damaged to salvage, which renders labral repair improbable and labral debridement ineffective. In contrast to other methods that have been described for this treatment, our technique uses a semitendinosus allograft as a graft source, allowing for arthroscopic hip labral reconstruction. This technique has many advantages and is easily reproducible. It has shown promising results in patients with labral damage. The purpose of this article is to detail the step‐by‐step surgical technique of labral reconstruction using a semitendinosus allograft, in addition to the indications, pearls, and pitfalls of the technique. Technique Video video See video under supplementary data.
Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy
Kumar, Seema , Coenen, Michael J., Bahn, Rebecca S. , Coenen, Michael, Iyer, Seethalakshmi

Thyroid | July 27, 2015 | Volume: 25 | Issue: 10 | Pages: 1145-1150

10.1089/thy.2015.0254 | PMID 26213859 Get It

Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma
Godby, Kelly, Kumar, Shaji , Costa, Luciano J. , Gonsalves, Wilson I. , Costa, Luciano J

American Journal of Hematology | July 27, 2015 | Volume: 91 | Issue: 1 | Pages: 101-108

10.1002/ajh.24129 | PMID 26214377 Get It

In the era of novel biological agents, multiple myeloma (MM) is often approached as a chronic condition. While survival continues to improve, population‐level data indicate that early mortality remains a substantial barrier to advances in MM outcomes. Here we provide “do's and don'ts” management recommendations that may minimize the risk of early mortality and ensure that patients have the opportunity to benefit from the long term impact of new effective MM agents. Such recommendations encompass the early introduction of novel agents even in the presence of comorbidities and advanced age and aggressive management of MM‐related complications. Am. J. Hematol. 91:101–108, 2016. © 2015 Wiley Periodicals, Inc.